We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+8.96%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.6B
AUM Growth
+$1.15B
(+1.6%)
Cap. Flow
-$3.6B
Cap. Flow
% of AUM
-4.89%
Top 10 Holdings %
Top 10 Hldgs %
20.8%
Holding
3,102
New
50
Increased
790
Reduced
2,114
Closed
100
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$38.7M |
| 2 |
International Flavors & Fragrances
IFF
|
+$27.4M |
| 3 |
Neurocrine Biosciences
NBIX
|
+$14.7M |
| 4 |
ConocoPhillips
COP
|
+$14.5M |
| 5 |
Royalty Pharma
RPRX
|
+$9.46M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$269M |
| 2 |
Microsoft
MSFT
|
+$172M |
| 3 |
Amazon
AMZN
|
+$114M |
| 4 |
Walt Disney
DIS
|
+$62.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$61.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.61% |
| 2 | Financials | 14.26% |
| 3 | Healthcare | 12.86% |
| 4 | Consumer Discretionary | 12.27% |
| 5 | Industrials | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CIM
1576
Chimera Investment
CIM
$1B
| $3.71M | 0.01% |
97,439
-10,955
| -10% | -$374K |
|
1577
National Bank Holdings
NBHC
$1.9B
| $3.71M | 0.01% |
93,513
+957
| +1% | +$35.8K |
|
|
CVGW
1578
DELISTED
Calavo Growers
CVGW
| $3.71M | 0.01% |
47,749
+162
| +0.3% | +$12.4K |
|
|
BPFH
1579
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
| $3.7M | 0.01% |
278,105
-4,206
| -1% | -$56.1K |
|
|
STAY
1580
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
| $3.69M | 0.01% |
186,814
-8,402
| -4% | -$137K |
|
1581
Coeur Mining
CDE
$17.9B
| $3.68M | 0.01% |
407,748
-33,823
| -8% | -$314K |
|
1582
CEVA Inc
CEVA
$1.08B
| $3.68M | 0.01% |
65,465
+1,254
| +2% | +$74.6K |
|
|
MAXR
1583
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $3.67M | 0.01% |
97,146
-18,048
| -16% | -$804K |
|
|
SAFE
1584
DELISTED
Safehold Inc.
SAFE
| $3.67M | 0.01% |
52,333
+504
| +1% | +$38.1K |
|
1585
Green Plains
GPRE
$1.03B
| $3.66M | 0.01% |
135,229
+14,651
| +12% | +$335K |
|
1586
Dime Commercial Bancshares
DCOM
$1.78B
| $3.65M | 0.01% |
121,205
-8,783
| -7% | -$251K |
|
1587
Ormat Technologies
ORA
$6.65B
| $3.65M | 0.01% |
46,419
-4,053
| -8% | -$401K |
|
|
BBT
1588
Beacon Financial Corp
BBT
$2.66B
| $3.63M | ﹤0.01% |
162,736
+619
| +0.4% | +$12.6K |
|
1589
McGrath RentCorp
MGRC
$2.92B
| $3.62M | ﹤0.01% |
44,904
-6,071
| -12% | -$466K |
|
|
AAMI
1590
Acadian Asset Management
AAMI
$3.19B
| $3.62M | ﹤0.01% |
177,546
+1,944
| +1% | +$38.3K |
|
|
AZEK
1591
DELISTED
The AZEK Co
AZEK
| $3.61M | ﹤0.01% |
85,856
+17,859
| +26% | +$764K |
|
1592
Kratos Defense & Security Solutions
KTOS
$11.4B
| $3.6M | ﹤0.01% |
132,098
-15,856
| -11% | -$444K |
|
|
SFIX
1593
Stitch Fix
SFIX
$560M
| $3.6M | ﹤0.01% |
72,759
-6,375
| -8% | -$449K |
|
1594
WesBanco
WSBC
$4B
| $3.59M | ﹤0.01% |
99,536
-7,938
| -7% | -$261K |
|
1595
Agios Pharmaceuticals
AGIO
$1.93B
| $3.57M | ﹤0.01% |
69,218
-1,866
| -3% | -$92.4K |
|
1596
Atkore
ATKR
$3.16B
| $3.57M | ﹤0.01% |
49,674
-7,085
| -12% | -$428K |
|
1597
Cardlytics
CDLX
$21.5M
| $3.56M | ﹤0.01% |
3,249
-68
| -2% | -$89.8K |
|
1598
United Parks & Resorts
PRKS
$2.12B
| $3.56M | ﹤0.01% |
71,596
-8,244
| -10% | -$327K |
|
|
BHVN
1599
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $3.55M | ﹤0.01% |
51,877
-6,890
| -12% | -$557K |
|
1600
Sturm, Ruger & Co
RGR
$593M
| $3.53M | ﹤0.01% |
53,412
+14,046
| +36% | +$967K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2021 Portfolio in Review
As of Q1 2021, RhumbLine Advisers held 3,102 positions worth $73.6B, up 1.6% from $72.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
RhumbLine Advisers withdrew a net $3.6B in Q1 2021, closing 100 positions and reducing 2,114 holdings. Its most notable exit was Tiffany & Co., an estimated $26.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
Against the trend, RhumbLine Advisers opened a new position in NXP Semiconductors worth $42.7M.
- RhumbLine Advisers's largest Q1 2021 buy was NXP Semiconductors: 211,843 shares worth $42.7M.
- RhumbLine Advisers added most to International Flavors & Fragrances in Q1 2021, an estimated $27.4M increase.
- RhumbLine Advisers's biggest Q1 2021 reduction was Apple, cutting an estimated $269M.
- RhumbLine Advisers fully exited Tiffany & Co. in Q1 2021, selling an estimated $26.8M.
- RhumbLine Advisers's ten largest holdings make up 21% of its $73.6B portfolio in Q1 2021.
- RhumbLine Advisers opened 50 new positions and closed 100 in Q1 2021.
- RhumbLine Advisers's portfolio value rose 1.6% quarter-over-quarter to $73.6B.
Based on RhumbLine Advisers's 13F filing for Q1 2021, filed 6 May 2021.